Persistence of disease flares is associated with an inadequate colchicine dose in familial Mediterranean fever: A national multicenter longitudinal study

J Allergy Clin Immunol Pract. 2021 Aug;9(8):3218-3220.e1. doi: 10.1016/j.jaip.2021.03.048. Epub 2021 Apr 20.
No abstract available

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colchicine
  • Familial Mediterranean Fever* / drug therapy
  • Familial Mediterranean Fever* / epidemiology
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Longitudinal Studies
  • Symptom Flare Up

Substances

  • Interleukin 1 Receptor Antagonist Protein
  • Colchicine